BioCentury
ARTICLE | Company News

Biotrace deal

February 13, 2006 8:00 AM UTC

Industrial microbiology developer BOI sold its Ruskinn Technology business to Ruskinn's management for about £1 million ($1.8 million) in cash. The new company, Ruskinn Life Sciences Ltd., will be bas...